NCT00174330 - Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia | Biotech Hunter

Enrollment

330

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

February 28, 2006

Conditions

HypertensionHyperlipidemia

Interventions

DRUG

atorvastatin

DRUG

amlodipine

Trial Locations (15)

100029

Pfizer Investigational Site, Beijing

100044

Pfizer Investigational Site, Beijing

100083

Pfizer Investigational Site, Beijing

110016

Pfizer Investigational Site, Shenyang

200003

Pfizer Investigational Site, Shanghai

200025

Pfizer Investigational Site, Shanghai

200032

Pfizer Investigational Site, Shanghai

200233

Pfizer Investigational Site, Shanghai

210029

Pfizer Investigational Site, Nanjing

300211

Pfizer Investigational Site, Tianjin

310016

Pfizer Investigational Site, Hangzhou

510080

Pfizer Investigational Site, Guangzhou

510100

Pfizer Investigational Site, Guangzhou

510515

Pfizer Investigational Site, Guangzhou

Unknown

Pfizer Investigational Site, Beijing

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY